We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EXFY:NASDAQExpensify, Inc. Analysis

Data as of 2026-04-01 - not real-time

$0.87

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Expensify’s stock is trading well below its short‑term and long‑term moving averages, with the price under the 20‑day, 50‑day and 200‑day SMAs, underscoring a bearish technical backdrop. The RSI sits in the mid‑40s, suggesting neither extreme oversold nor overbought conditions, while the MACD histogram has turned positive, offering a modest bullish signal amid overall weakness. Volatility is exceptionally high, exceeding 100% over the past month, and beta is above one, indicating the stock moves more aggressively than the market.
On the fundamentals side, the company posted a revenue decline year‑over‑year but generated solid free cash flow and operating cash flow, a rare positive in a loss‑making SaaS business. Valuation metrics are compelling: the price‑to‑book is well under one, the forward P/E is far below the industry average, and a discounted cash flow model implies a fair value more than four times the current price, pointing to a sizeable upside potential. However, margins remain thin, profitability is negative, and the balance sheet shows modest leverage. Overall, the stock offers a high‑risk, high‑reward profile, with technical weakness offset by a deep valuation gap and cash generation.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below key moving averages
  • High short‑term volatility
  • Bullish MACD histogram but overall bearish trend

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation upside relative to DCF
  • Positive free cash flow generation
  • Low price‑to‑book and forward P/E versus peers

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Deep valuation discount and potential for margin improvement
  • Scalable SaaS platform with expanding user base
  • Resilient cash position despite modest debt

Key Metrics & Analysis

Financial Health

Revenue Growth-4.90%
Profit Margin-15.05%
P/E Ratio9.3
ROE-16.39%
ROA-6.26%
Debt/Equity4.32
P/B Ratio0.6
Op. Cash Flow$20.1M
Free Cash Flow$27.0M
Industry P/E33.2

Technical Analysis

TrendBearish
RSI43.6
Support$0.69
Resistance$1.05
MA 20$0.85
MA 50$1.12
MA 200$1.64
MACDBullish
VolumeStable
Fear & Greed Index77.61

Valuation

Fair Value$4.53
Target Price$1.50
Upside/Downside72.10%
GradeUndervalued
TypeValue

Risk Assessment

Beta1.15
Volatility106.97%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.